Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
189.00    0.00 (0.00%)
Bid:
188.20
Ask:
189.00
Spread: 0.80 (0.425%)
Market Cap: £504.78m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

28 Apr 2025 12:32

RNS Number : 4662G
Costain Group PLC
28 April 2025
 

 

 

Costain Group PLC (the 'Company')

28 April 2025

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the final dividend for the year ending 31 December 2024 is 104.88 pence per ordinary share.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 17 April 2025.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the final dividend for the year ending 31 December 2024 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 7 May 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The final dividend for the year ending 31 December 2024, including the scrip dividend, will be paid on 29 May 2025 (the dividend payment date), subject to approval at the 2025 Annual General Meeting on 15 May 2025, to the ordinary shareholders of the Company on the register at close of business on 22 April 2025 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

Investors and analysts

Matt Jones, Costain

matt.jones@costain.com

+44 (0)7860 922341

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997365

Charlie Twigg

+44 (0) 7946 494568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUBPCUPAGGR
Date   Source Headline
3rd Nov 202511:59 amRNSTotal Voting Rights
30th Oct 20253:08 pmRNSHolding(s) in Company
28th Oct 20252:48 pmRNSHolding(s) in Company
27th Oct 20252:47 pmRNSHolding(s) in Company
24th Oct 202512:05 pmRNSHolding(s) in Company
21st Oct 20254:13 pmRNSHolding(s) in Company
17th Oct 20255:07 pmRNSHolding(s) in Company
17th Oct 202511:26 amRNSHolding(s) in Company
14th Oct 20253:34 pmRNSAdditional Listing
13th Oct 202511:42 amRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSCostain Secures £1bn Programme With Sellafield
6th Oct 202510:59 amRNSHolding(s) in Company
18th Sep 20252:00 pmRNSScrip Dividend Reference Price
1st Sep 202511:07 amRNSTotal Voting Rights
28th Aug 20259:05 amRNSDirector/PDMR Shareholding
22nd Aug 20253:28 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHalf-year Report
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20259:07 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20255:23 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20252:39 pmRNSHolding(s) in Company
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202510:47 amRNSHolding(s) in Company
1st Aug 202510:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202510:40 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20253:03 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSInvestor Presentation via Investor Meet Company
28th Jul 20252:11 pmRNSHolding(s) in Company
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20252:25 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 202511:03 amRNSHolding(s) in Company
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 202510:41 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.